Latest Breaking News On - Augmedix go assist - Page 3 : comparemela.com

Augmedix, Inc (NASDAQ:AUGX) Insider Ian Shakil Sells 24,778 Shares

Augmedix, Inc (NASDAQ:AUGX) Insider Ian Shakil Sells 24,778 Shares
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesMian shakilThompson davisAugmedix incAcadian asset managementBarclays plcMaxim groupWorth venture partnersSymmetry peak managementGet free reportAsset managementVenture partnersSpeak managementAugmedix liveAugmedix go assistAugmedix prep

Ian Shakil Sells 37,780 Shares of Augmedix, Inc (NASDAQ:AUGX) Stock

Augmedix, Inc. (NASDAQ:AUGX – Get Free Report) insider Ian Shakil sold 37,780 shares of the business’s stock in a transaction that occurred on Monday, April 8th. The stock was sold at an average price of $3.97, for a total value of $149,986.60. Following the transaction, the insider now owns 3,000 shares in the company, valued […]

United statesMian shakilVontobel holding ltdAugmedix company profilePortside wealth groupAugmedix incLegato capital managementMaxim groupTaylor frigon capital managementTucker asset managementGet free reportWealth groupAsset managementCapital managementAugmedix liveAugmedix go assist

Evercore ISI Upgrades Augmedix (NASDAQ:AUGX) to Outperform

Augmedix (NASDAQ:AUGX – Get Free Report) was upgraded by analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a report issued on Tuesday, Benzinga reports. The firm presently has a $5.00 price objective on the stock, up from their previous price objective of $4.50. Evercore ISI’s target price indicates a potential […]

United statesMian shakilAugmedix company profileSecurities exchange commissionVerition fund managementSymmetry peak managementMaxim groupAcadian asset managementAugmedix incWorth venture partnersThompson davisGet free reportExchange commissionAsset managementSpeak managementVenture partners

Evercore ISI Upgrades Augmedix (NASDAQ:AUGX) to Outperform

Augmedix (NASDAQ:AUGX – Get Free Report) was upgraded by analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a report issued on Tuesday, Benzinga reports. The firm presently has a $5.00 price objective on the stock, up from their previous price objective of $4.50. Evercore ISI’s target price indicates a potential […]

United statesMian shakilWorth venture partnersThompson davisSecurities exchange commissionAugmedix company profileMaxim groupAcadian asset managementSymmetry peak managementVerition fund managementAugmedix incGet free reportExchange commissionAsset managementSpeak managementVenture partners

Evercore ISI Upgrades Augmedix (NASDAQ:AUGX) to Outperform

Augmedix (NASDAQ:AUGX – Get Free Report) was upgraded by investment analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a research report issued on Tuesday, Benzinga reports. The brokerage presently has a $5.00 target price on the stock, up from their previous target price of $4.50. Evercore ISI’s price objective indicates […]

United statesMian shakilWorth venture partnersNorthern trust corpVontobel holding ltdAugmedix company profileSecurities exchange commissionAugmedix incSymmetry peak managementMaxim groupAcadian asset managementGet free reportExchange commissionAsset managementSpeak managementVenture partners